title: Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease.
authors.affiliation: Department of Pharmaceutical Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48202, USA.
authors.forename: Sanjib
authors.initials: S
authors.lastname: Gogoi
authors.forename: Tamara
authors.initials: T
authors.lastname: Antonio
authors.forename: Subramanian
authors.initials: S
authors.lastname: Rajagopalan
authors.forename: Maarten
authors.initials: M
authors.lastname: Reith
authors.forename: Julie
authors.initials: J
authors.lastname: Andersen
authors.forename: Aloke K
authors.initials: AK
authors.lastname: Dutta
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000737:chemistry / Q000627:therapeutic use*; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D007502:Iron Chelating Agents / Q000737:chemistry / Q000627:therapeutic use*; D051379:Mice; D018696:Neuroprotective Agents / Q000737:chemistry / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D051381:Rats; D017448:Receptors, Dopamine D2 / Q000819:agonists*; D050637:Receptors, Dopamine D3 / Q000819:agonists*
chemical_list: D000975:Antioxidants; D007502:Iron Chelating Agents; D018696:Neuroprotective Agents; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3